Acquiring Company
Hikma Pharmaceuticals
Acquired Company
Hikma Pharmaceuticals
OhioOhioManufacturingBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyHealth CarePharmaceuticalDescription
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. ('Custopharm') from Water Street Healthcare Partners ('Water Street'), following approval from the US Federal Trade Commission.
Who to call at Hikma Pharmaceuticals, and when
When Hikma Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Hikma Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hikma Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hikma Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hikma Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Hikma Pharmaceuticals?
Hikma Pharmaceuticals was acquired by Hikma Pharmaceuticals, based in Ohio. The deal was reported on April 21, 2022. Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. Hikma Pharmaceuticals is privately held and operates in Manufacturing.
When did Hikma Pharmaceuticals acquire Hikma Pharmaceuticals?
Hikma Pharmaceuticals's acquisition of Hikma Pharmaceuticals was reported on April 21, 2022. Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Hikma Pharmaceuticals do?
Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. The company specializes in the manufacturing of complex generics, particularly sterile injectables, aimed at addressing the growing demand for oncology and chronic-care drugs. It is privately held, operating in Manufacturing, and is based in Ohio.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.